Outcomes of Long Pouch Gastric Bypass (LPGB): 4-Year Experience in Primary and Revision Cases.
Biliary reflux
EBAR
Entero bilioacid reflux
Hypoglycaemia
LPGB
Long pouch gastric bypass
Morbid obesity
Roux-en-Y diversion
Journal
Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714
Informations de publication
Date de publication:
11 2019
11 2019
Historique:
pubmed:
4
7
2019
medline:
23
5
2020
entrez:
4
7
2019
Statut:
ppublish
Résumé
One of the most important complications of the one anastomosis gastric bypass (OAGB) is enterobilio acid reflux (EBAR). We report the concept of the long pouch Roux-en-Y gastric bypass (LPRYGB) meaning a Roux-en-Y with a long pouch and a 100-cm alimentary limb to avoid EBAR, with a long biliopancreatic limb to increase metabolic effects. A total of 300 LPRYGB cases in a 4-year period, with a 90% follow-up rate, were analysed. Anthropometric, technical feasibility, morbidity, weight loss and comorbidity outcomes were analysed. The percentage total weight loss (%TWL) was 30.5% at 4 years of follow-up (32.3% in primary and 28.3% in revisions). Six intra-operative (2%) and 28 postoperative complications (9.3%) were seen. Out of this 28 complications, 11 (3.6%) were late complications. Reoperations were performed in 15 patients (5.0%). Clinically relevant EBAR was present in 3 cases only (1%) 4 years after the operation. The LPRYGB combines the main advantages of the OAGB (light restriction and moderate malabsorption) with the anti-reflux effect from the Roux-en-Y diversion.
Sections du résumé
BACKGROUND
One of the most important complications of the one anastomosis gastric bypass (OAGB) is enterobilio acid reflux (EBAR). We report the concept of the long pouch Roux-en-Y gastric bypass (LPRYGB) meaning a Roux-en-Y with a long pouch and a 100-cm alimentary limb to avoid EBAR, with a long biliopancreatic limb to increase metabolic effects.
METHODS
A total of 300 LPRYGB cases in a 4-year period, with a 90% follow-up rate, were analysed. Anthropometric, technical feasibility, morbidity, weight loss and comorbidity outcomes were analysed.
RESULTS
The percentage total weight loss (%TWL) was 30.5% at 4 years of follow-up (32.3% in primary and 28.3% in revisions). Six intra-operative (2%) and 28 postoperative complications (9.3%) were seen. Out of this 28 complications, 11 (3.6%) were late complications. Reoperations were performed in 15 patients (5.0%). Clinically relevant EBAR was present in 3 cases only (1%) 4 years after the operation.
CONCLUSIONS
The LPRYGB combines the main advantages of the OAGB (light restriction and moderate malabsorption) with the anti-reflux effect from the Roux-en-Y diversion.
Identifiants
pubmed: 31267476
doi: 10.1007/s11695-019-04051-8
pii: 10.1007/s11695-019-04051-8
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3665-3671Commentaires et corrections
Type : ErratumIn
Type : ErratumIn
Type : ErratumIn
Références
Thorax. 1976 Jun;31(3):271-7
pubmed: 941112
Clin Obes. 2016 Feb;6(1):61-7
pubmed: 26781603
Medicine (Baltimore). 2018 Jun;97(22):e10927
pubmed: 29851828
Obes Surg. 2012 May;22(5):697-703
pubmed: 22411569
Obes Surg. 2015 Oct;25(10):1833-41
pubmed: 25736230
Ann Surg. 2016 Nov;264(5):878-885
pubmed: 27560624
Obes Surg. 2014 Feb;24(2):324-33
pubmed: 24101089
Medicine (Baltimore). 2017 Dec;96(48):e8859
pubmed: 29310367
Obes Surg. 2016 Jun;26(6):1322-3
pubmed: 27091050
N Engl J Med. 2017 Sep 21;377(12):1143-1155
pubmed: 28930514
World J Gastroenterol. 2014 Jun 28;20(24):7730-8
pubmed: 24976710
Surg Endosc. 2019 Feb;33(2):401-410
pubmed: 29943058
Arq Bras Cir Dig. 2014;27 Suppl 1:2-8
pubmed: 25409956
JAMA. 2014 Jun 11;311(22):2297-304
pubmed: 24915261
Obes Surg. 2018 May;28(5):1441-1444
pubmed: 29516398
Obes Surg. 2019 Mar;29(3):811-818
pubmed: 30560312
Ann Surg. 2016 Nov;264(5):871-877
pubmed: 27429035
Obes Surg. 2012 Dec;22(12):1827-34
pubmed: 23011462
Obes Surg. 2017 Nov;27(11):2956-2967
pubmed: 28569357
Arq Bras Cir Dig. 2013;26 Suppl 1:22-5
pubmed: 24463894
Surg Obes Relat Dis. 2016 Aug;12(7):1357-1363
pubmed: 27387699
Obes Surg. 2017 May;27(5):1153-1167
pubmed: 27783366
Surg Clin North Am. 1967 Dec;47(6):1345-51
pubmed: 6073761
Obes Surg. 2018 Sep;28(9):2956-2967
pubmed: 29995293
Surg Endosc. 2017 Sep;31(9):3504-3509
pubmed: 27981383
Surg Obes Relat Dis. 2009 Jan-Feb;5(1):27-30
pubmed: 19095503
Surg Endosc. 2014 Jan;28(1):156-63
pubmed: 23982648
Surg Endosc. 2003 Jul;17(7):1055-60
pubmed: 12728380
Ann Thorac Surg. 2005 Nov;80(5):1938-40
pubmed: 16242496
Surgery. 1980 Mar;87(3):280-5
pubmed: 6767288
Gastrointest Endosc. 1976 May;22(4):197-9
pubmed: 57898
Ann Surg. 1954 Sep;140(3):439-48
pubmed: 13198079
Obes Surg. 2018 Mar;28(3):599-605
pubmed: 28933045
Surg Obes Relat Dis. 2007 Jan-Feb;3(1):37-41
pubmed: 17196443
Obes Surg. 2016 Jul;26(7):1592-3
pubmed: 27061594
Surg Endosc. 2006 Jun;20(6):850-4
pubmed: 16738968
Int J Surg Case Rep. 2017;30:148-151
pubmed: 28012332
Ann Surg. 2005 Jul;242(1):20-8
pubmed: 15973097
Am J Surg. 2003 Sep;186(3):269-73
pubmed: 12946831
Ann Surg. 2006 Nov;244(5):734-40
pubmed: 17060766
Surg Obes Relat Dis. 2015 Mar-Apr;11(2):321-6
pubmed: 25614356